Barclays analyst Hassan Al-Wakeel lowered the firm’s price target on Vimian (VIMGF) to SEK 25 from SEK 27 and keeps an Underweight rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VIMGF:
- Vimian: Stabilising Fundamentals but Uneven Profitability Support a Fair Valuation and Hold Rating
- Vimian posts solid 2025 growth and upgrades to Nasdaq Main Market
- Vimian to Present 2025 Year-End Results in February Webcast
- Vimian’s Specialty Pharma Chief to Step Down in Spring 2026
- Vimian Updates Share Capital and Voting Rights After Incentive Programme Issues